Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Monica Farley"'
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Carbapenem-resistant Enterobacterales (CRE) infections are a public health threat due to the risk of transmission between patients and high associated mortality. We sought to identify risk factors for mortality in patients with i
Externí odkaz:
https://doaj.org/article/725fcfcbb1a846d2aa7ba7e8ced5d9d9
Autor:
Ruth Link-Gelles, Daniel Westreich, Allison E. Aiello, Nong Shang, David J. Weber, Corinne Holtzman, Karen Scherzinger, Arthur Reingold, William Schaffner, Lee H. Harrison, Jennifer B. Rosen, Susan Petit, Monica Farley, Ann Thomas, Jeffrey Eason, Christine Wigen, Meghan Barnes, Ola Thomas, Shelley Zansky, Bernard Beall, Cynthia G. Whitney, Matthew R. Moore
Publikováno v:
SSM: Population Health, Vol 2, Iss , Pp 587-594 (2016)
In 2010, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the US for prevention of invasive pneumococcal disease in children. Individual-level socioeconomic status (SES) is a potential confounder of the estimated effectiveness of PC
Externí odkaz:
https://doaj.org/article/12e51f0014bd4c77acdbc7c682510c2c
Publikováno v:
Journal of Clinical and Translational Science, Vol 3, Pp 56-57 (2019)
OBJECTIVES/SPECIFIC AIMS: The overall goal of this project is to determine whether timing of seasonal influenza vaccination affects the severity of illness in vaccinated individuals who are hospitalized with influenza. This will be assessed with the
Externí odkaz:
https://doaj.org/article/3b5db0b7bc8b42f8a6884fa799cc9310
Autor:
Sara E Oliver, Adam C Retchless, Amy E Blain, Lucy A McNamara, Susann Ahrabifard, Monica Farley, Don Weiss, Elizabeth Zaremski, Xin Wang, Susan Hariri
Publikováno v:
Open Forum Infectious Diseases. 9
We describe cases of invasive meningococcal disease caused by nongroupable Neisseria meningitidis belonging to a novel phylogenetic clade associated with urethritis. Seven cases were identified, comprising 0.6% of sequenced invasive meningococcal dis
Autor:
Sara E, Oliver, Adam C, Retchless, Amy E, Blain, Lucy A, McNamara, Susann, Ahrabifard, Monica, Farley, Don, Weiss, Elizabeth, Zaremski, Xin, Wang, Susan, Hariri
Publikováno v:
Open Forum Infect Dis
We describe cases of invasive meningococcal disease caused by nongroupable Neisseria meningitidis belonging to a novel phylogenetic clade associated with urethritis. Seven cases were identified, comprising 0.6% of sequenced invasive meningococcal dis
Autor:
Tamara Pilishvili, Ryan Gierke, Monica Farley, William Schaffner, Ann Thomas, Arthur Reingold, Lee Harrison, Ruth Lynfield, S. Zansky, Susan Petit, Lisa Miller, Joseph Bareta, Bernard Beall, Matthew R. Moore, Cynthia Whitney
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Susan N. Hocevar, Sandra N. Bulens, Monica Farley, Stacy Holzbauer, Emily B. Hancock, Ghinwa Dumyati, Corinne M. Davis, Carol Lyons, Rebecca Perlmutter, Erin Parker, Claire Reisenauer, Valerie L. S. Ocampo, Yi Mu, L. Clifford Mcdonald
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Frederick J. Angulo, Andrew C. Voetsch, David L. Swerdlow, null FoodNet Working Group, Duc Vugia, James L. Hadler, Monica Farley, Craig Hedberg, Paul Cieslak, Dale Morse, Diane Dwyer
Publikováno v:
Veterinary Clinics of North America: Food Animal Practice. 14:165-172
Food borne diseases cause a significant burden of illness in the United States. The Food Borne Diseases Active Surveillance Network (FoodNet), established in 1995, continues to monitor the burden and causes of food borne diseases and provide much of
Autor:
Monica Farley, Amita Patnaik, Teresa L. Vaught, A. Rosenthal, Justin Meade, Michael J. Wick, Lizette Gamez, Drew W. Rasco, Ronald Drengler, Kyri Papadopoulos, Anthony W. Tolcher
Publikováno v:
Cancer Research. 76:P3-03
Preclinical in vivo models of estrogen receptor positive (ER+) breast cancer rely on exogenous supplementation of hormones for growth. This requirement leads to animal toxicity and mortality over time, limiting development and drug testing in these t
Autor:
Anthony W. Tolcher, Elena Helman, Monica Farley, Scott Ulmer, Kyriakos P. Papadopoulos, Lizette Gamez, Drew W. Rasco, Teresa L. Vaught, Amita Patnaik, Alyssa Moriarty, Michael J. Wick, Michael J. Clark
Publikováno v:
Molecular Cancer Therapeutics. 14:A18-A18
Background: A subset of non-small cell lung cancer (NSCLC) is driven by mutations or deletions in the epithelial growth factor receptor (EGFR). Several targeted therapies including gefitinib and erlotinib are initially effective towards EGFR-mutant N